Oxford Asset Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$114K Buy
25,309
+2,104
+9% +$11K 0.05% 404
2025
Q4
$143K Buy
+23,205
New +$168K 0.05% 417
2025
Q3
Sell
-33,964
Closed -$180K 629
2025
Q2
$180K Buy
33,964
+4,770
+16% +$28.2K 0.06% 435
2025
Q1
$259K Buy
+29,194
New +$351K 0.12% 290
2019
Q3
Sell
-11,079
Closed -$308K 1866
2019
Q2
$308K Sell
11,079
-1,978
-15% -$55.9K 0.01% 1439
2019
Q1
$433K Buy
+13,057
New +$397K 0.01% 1281
2018
Q4
Sell
-37,947
Closed -$1.75M 1972
2018
Q3
$1.75M Buy
37,947
+1,628
+4% +$72.4K 0.04% 736
2018
Q2
$1.35M Buy
+36,319
New +$1.23M 0.03% 883
2018
Q1
Sell
-76,588
Closed -$2.65M 1795
2017
Q4
$2.65M Sell
76,588
-144,392
-65% -$4.87M 0.06% 439
2017
Q3
$7.99M Buy
220,980
+18,988
+9% +$542K 0.15% 114
2017
Q2
$5.22M Sell
201,992
-11,289
-5% -$240K 0.1% 203
2017
Q1
$4.09M Buy
213,281
+44,116
+26% +$782K 0.1% 196
2016
Q4
$2.82M Buy
169,165
+39,339
+30% +$712K 0.1% 210
2016
Q3
$2.67M Sell
129,826
-18,766
-13% -$476K 0.08% 339
2016
Q2
$4.55M Buy
+148,592
New +$5.16M 0.15% 163
2016
Q1
Sell
-82,519
Closed -$3.6M 856
2015
Q4
$3.6M Sell
82,519
-14,168
-15% -$599K 0.08% 257
2015
Q3
$3.62M Sell
96,687
-130,276
-57% -$4.62M 0.11% 185
2015
Q2
$7.71M Sell
226,963
-110,770
-33% -$3.77M 0.21% 111
2015
Q1
$12M Sell
337,733
-18,540
-5% -$664K 0.3% 58
2014
Q4
$12.4M Sell
356,273
-17,784
-5% -$631K 0.27% 58
2014
Q3
$14.4M Sell
374,057
-15,603
-4% -$582K 0.33% 50
2014
Q2
$15.3M Sell
389,660
-104,079
-21% -$3.87M 0.5% 33
2014
Q1
$16.9M Sell
493,739
-133,304
-21% -$4.13M 0.49% 32
2013
Q4
$13.2M Buy
627,043
+392,517
+167% +$9.93M 0.33% 54
2013
Q3
$5.51M Buy
234,526
+26,256
+13% +$746K 0.12% 210
2013
Q2
$5.6M Buy
+208,270
New +$6.04M 0.15% 210

Other funds holding MYGN